This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Depression  • Alert me on articles by topic  Social Bookmarking   What's this?

Erin E. Hartman, MS; Jennifer Daley, MD
From the Division of General Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave, LY318, Boston, MA 02215.

JAMA. 1999;282:770.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

At Obstetrics and Gynecology Grand Rounds in May 1998, Barbara L. Parry, MD, discussed the diagnostic criteria for premenstrual dysphoric disorder (PMDD), along with its relationship to other psychiatric disorders.¹ Ms V, the patient, had disabling symptoms of mood swings, irritability, and depression prior to her menses since menarche. Over the years, physicians prescribed several medications and recommended dietary modifications, vitamins, and exercise, none of which provided consistent relief. For 9 months in 1996, Ms V took fluoxetine, which improved her symptoms of PMDD, but caused troubling adverse effects so that she stopped taking the medication. Dr Parry explained the importance of a careful medical history and stressed that any underlying conditions be addressed before treating PMDD. For patients who meet the criteria for PMDD after 2 consecutive cycles, Dr Parry recommended counseling and other treatment strategies, such as stress reduction, vitamin supplements, . . . [Full Text of this Article]

MRS V, THE PATIENT



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?